InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-01 | Huang James | Director | Purchase | 1.16M | $3.45 | $4.00M | 13.16M | View ↗ |
No annual data found.
Connect Biopharma: New Market Opportunity In The Emergency Setting
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update